AMERISAFE (NASDAQ:AMSF - Get Free Report) is expected to be posting its Q3 2025 results after the market closes on Wednesday, October 29th. Analysts expect AMERISAFE to post earnings of $0.55 per share and revenue of $78.2860 million for the quarter. Investors can check the company's upcoming Q3 2025 earningsummary page for the latest details on the call scheduled for Thursday, October 30, 2025 at 10:30 AM ET.
AMERISAFE (NASDAQ:AMSF - Get Free Report) last issued its earnings results on Thursday, July 24th. The insurance provider reported $0.53 EPS for the quarter, missing the consensus estimate of $0.55 by ($0.02). AMERISAFE had a return on equity of 16.54% and a net margin of 16.46%.The company had revenue of $79.70 million during the quarter, compared to the consensus estimate of $77.30 million. On average, analysts expect AMERISAFE to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
AMERISAFE Stock Down 0.0%
Shares of AMSF opened at $41.76 on Wednesday. AMERISAFE has a twelve month low of $40.03 and a twelve month high of $60.24. The stock has a market cap of $793.06 million, a PE ratio of 15.82 and a beta of 0.32. The business's 50-day moving average price is $44.13 and its 200-day moving average price is $45.41.
Analysts Set New Price Targets
A number of equities research analysts have recently issued reports on the stock. Wall Street Zen raised shares of AMERISAFE from a "sell" rating to a "hold" rating in a report on Sunday, August 17th. Truist Financial lowered their price target on shares of AMERISAFE from $54.00 to $50.00 and set a "hold" rating on the stock in a report on Monday, July 28th. JMP Securities lowered their price target on shares of AMERISAFE from $65.00 to $60.00 and set a "market outperform" rating on the stock in a report on Tuesday, October 14th. Finally, Weiss Ratings reissued a "hold (c)" rating on shares of AMERISAFE in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, AMERISAFE presently has an average rating of "Hold" and an average price target of $55.00.
Read Our Latest Analysis on AMSF
Insider Activity
In other news, CFO Anastasios Omiridis sold 1,343 shares of AMERISAFE stock in a transaction dated Tuesday, August 5th. The stock was sold at an average price of $44.75, for a total transaction of $60,099.25. Following the completion of the sale, the chief financial officer owned 2,253 shares in the company, valued at approximately $100,821.75. This trade represents a 37.35% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 1.61% of the company's stock.
Hedge Funds Weigh In On AMERISAFE
Large investors have recently modified their holdings of the company. Tower Research Capital LLC TRC raised its holdings in shares of AMERISAFE by 87.9% during the 2nd quarter. Tower Research Capital LLC TRC now owns 1,920 shares of the insurance provider's stock valued at $84,000 after buying an additional 898 shares in the last quarter. BNP Paribas Financial Markets raised its holdings in shares of AMERISAFE by 116.9% during the 2nd quarter. BNP Paribas Financial Markets now owns 2,713 shares of the insurance provider's stock valued at $119,000 after buying an additional 1,462 shares in the last quarter. Caxton Associates LLP purchased a new position in shares of AMERISAFE during the 2nd quarter valued at about $316,000. Quantbot Technologies LP purchased a new position in shares of AMERISAFE during the 2nd quarter valued at about $349,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of AMERISAFE by 4.3% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,313 shares of the insurance provider's stock valued at $594,000 after buying an additional 471 shares in the last quarter. 97.41% of the stock is owned by hedge funds and other institutional investors.
About AMERISAFE
(
Get Free Report)
AMERISAFE, Inc, an insurance holding company, underwrites workers' compensation insurance in the United States. The company provides benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It sells its products through retail and wholesale brokers and agents; and small and mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider AMERISAFE, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMERISAFE wasn't on the list.
While AMERISAFE currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.